Results for tag: "Upper Limb Hypertonia Drug"

Upper Limb Hypertonia Drug market is a segment of the Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat upper limb hypertonia, a condition characterized by increased muscle tone in the arms and hands. These drugs are used to reduce spasticity, improve range of motion, and reduce pain. Commonly used drugs include botulinum toxin, baclofen, and diazepam. Other treatments such as physical therapy, occupational therapy, and electrical stimulation may also be used. The Upper Limb Hypertonia Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Allergan, Merz Pharmaceuticals, Ipsen, Novartis, and Teva Pharmaceuticals. Other companies such as AbbVie, Mylan, and Sun Pharmaceuticals also have a presence in the market. Show Less Read more